Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 distinguished luminal A-like breast cancer from luminal B-like disease based on immunohistochemical stains of ER, PR, and Ki-67 status without a requirement for molecular diagnostics. This evidence concerns the gene MKI67 and breast cancer.